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Insertion of organometallic moieties into
peptides and peptide nucleic acids using
alternative “click” strategies†
Cristina Mari, Sandro Mosberger, Nuria Llorente, Sarah Spreckelmeyer and
Gilles Gasser*
The insertion of metal complexes in biologically active systems is of great interest in view of diagnostic
and therapeutic applications as well as a precious tool to unveil biological mechanisms. Optimization of
safe and biocompatible reactions is critical to achieve high functionalization eﬃciency. Herein we present
the application of two modiﬁed versions of copper-catalyzed azide–alkyne cycloaddition (click) chem-
istry, namely a one-pot diazotransfer + azide–alkyne cycloaddition (one-pot click) and a copper-free
photoactivated tetrazole–alkene cycloaddition (photoclick), for derivatization of peptides and peptide
nucleic acids (PNAs) with ferrocene and cymantrene moieties. These metal fragments were chosen for
their possible exploitation as redox and IR probes. We could demonstrate that one-pot click enables for
eﬃcient functionalization of propargyl-glycine and an alkyne-containing peptide with an amino-contain-
ing cymantrene precursor. In addition, we could show that photoclick allows for the insertion of male-
imido-ferrocene into a peptide and a PNA sequence containing a tetrazole moiety.
Introduction
The functionalization of biologically active molecules is of
great importance nowadays in medicinal chemistry.1–3 In par-
ticular, their functionalization with metal-based compounds
can confer novel properties to the formed bioconjugate com-
pared to the biomolecule itself allowing for novel appli-
cations.4 Metal complexes can be used as both diagnostic and
therapeutic tools in the clinical treatment of patients.5 The
coupling of a targeting vector (i.e. peptide, antibody, etc.) to
therapeutic/diagnostic metal-based drugs can, for example,
increase their organ/cell selectivity.6–10 In a similar vein, the
insertion of metal fragments into biologically active molecules
can yield biocompatible and extremely useful tools for biologi-
cal investigations, such as luminescent probes.11
The application of copper-catalyzed azide–alkyne cyclo-
addition (CuAAC, commonly referred to as click chemistry) for
bioconjugation has been extensively exploited due to the high
versatility, selectivity and functional group tolerance of this
synthetic technique.12 A great number of probes, including
metal-containing probes, were “clicked” to an important variety
of biologically active compounds such as peptides, antibodies,
peptide nucleic acids (PNAs) or polymers.13–17 However, this
reaction presents two important drawbacks from both a chemi-
cal as well as a biological point of view. Since an azide is one of
the protagonists of this transformation, this functional group
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has to be installed on one of the two molecules to be coupled.
Safety concerns about the isolation of azides (especially with low
molecular weight compounds) are still actual nowadays due to
the potential instability of this class of compounds.18 Therefore,
from a chemical point of view, it would be more convenient to
skip the azide isolation, for example, via an in situ insertion of
this functionality. The second disadvantage of the CuAAC is its
reliability on the presence of CuI as catalyst for its mechanism
to take place. This situation represents a problem for in cellulo
applications of the technique due to the toxicity of the
metal.13,19 To address these limitations, a great eﬀort has been
made towards the optimization of new methodologies for click-
mediated biocompatible conjugation.13,20,21 Since the absence
of a Cu catalyst makes the click reaction very ineﬃcient, an
alternative activation mechanisms had to be developed. Among
the most relevant examples, Strain-Promoted Inverse Electron
Demand Diels–Alder Cycloaddition (SPIEDAC) and Strain-Pro-
moted Alkyne–Azide Cycloaddition (SPAAC) exploit the for-
mation of an unstrained product as reaction driving force,
circumventing the need of Cu catalysis.19 Other approaches
involve the use of light to form a reactive intermediate.21
Herein, we present, to the best of our knowledge, the first
examples of the application of two modified versions of the
classical CuAAC to introduce organometallic fragments into
biologically active molecules, namely a peptide and a PNA oligo-
mer (see Fig. 2). In particular, we focused our attention on
two modified click reactions, namely the copper-catalyzed one-
pot diazotransfer + azide–alkyne cycloaddition reaction (which
will be called from now on in this article one-pot click)22 and
the metal-free photoactivated tetrazole–alkene cycloaddition
(referred to from now on as photoclick).23 The two organo-
metallic components investigated in this study were a cymantrene
derivative A and a ferrocene derivative B (Fig. 1),24,25 chosen
for their potential use as IR (A) and redox (B) probes in a bio-
logical environment.26,27
Results and discussion
One-pot click reaction
The one-pot click reaction developed by Wittmann et al. allows
in a subtle manner to circumvent the isolation of the azide
intermediate.22 More specifically, the one-pot click proceeds via
two subsequent steps. First, an amine derivative is turned into
an azide via a CuII catalyzed diazotransfer. This intermediate
can then be clicked to an alkyne by the classical CuAAC reac-
tion. The CuI catalyst for the click reaction is formed in situ by
addition of a reducing agent to the mixture. In the present
study, we applied this synthetic technique to the two amino-
organometallic derivatives A and B. These molecules were
clicked to an unnatural amino acid carrying a propargyl group
(Fmoc-L-Pra-OH) and a short peptide containing this amino
acid (NLS-Pra, Fig. 2). This small peptide is known for its
nuclear targeting properties and has been used in the past by
our group to deliver diﬀerent metal complexes to the cell
nucleus.6,28,29 NLS-Pra was synthesized by standard solid
phase synthesis and the alkynyl containing unnatural amino
acid was inserted at the N-terminus.28 The original one-pot
click procedure reported by Wittmann et al. was followed in
this study with the exception of minor modifications: the
amounts of copper salt, tris(benzyltriazolylmethyl)amine
(TBTA) and sodium ascorbate were doubled and the reaction
duration was extended to 1 h of microwave assisted refluxing,
instead of 30 minutes. When A was used as the amine precur-
sor, the reaction was found to be eﬀective for labelling both
the amino acid and the peptide (Fig. 3).
More specifically, product 2A was isolated in 50% yield and
its structure confirmed by several analytical techniques. The
UPLC-MS chromatogram showed one peak, whose integrated
mass of m/z 694.2 is attributable to [M + H]+. The nature of 2A
was further confirmed by HR ESI-MS, in which the peak of
[M − H]− is visible. In addition, the IR spectrum clearly
showed the characteristic vibrations of the CuO groups at
1921 and 2015 cm−1. However, due to the presence of traces
amounts of a paramagnetic impurity, we were unable to
obtain a good 1H-NMR spectrum. In the 13C-NMR, however,
resonances at 55.73 and 29.22 ppm can be attributed to the
CH2 and CH carbons between the newly formed triazole and
the COOH moiety. The peptide derivative 3A was isolated via
preparative RP-HPLC purification. UPLC-MS analysis showed
Fig. 1 Structures of the organometallic complexes used in this paper
and their simpliﬁed depictions.
Fig. 2 Structures of the peptides and PNA to be “clicked”. All amine groups in peptide and PNA sequences are present as TFA salts.
Research Article Inorganic Chemistry Frontiers
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one peak in the chromatogram, with the m/z values assigned
to the product with multiple charges. MALDI-TOF analysis
also showed the expected peak at m/z 1289.6 corresponding to
[M + H]+, but also the typical fragmentation of [M + H −
Mn(CO)3]
+. Such a fragmentation was already reported for
similar biomolecules.30 As further confirmation of the identity
of the compound, the IR spectrum of 3A showed the vibrations
of the CuO at 1927 and 2017 cm−1. When the Fc precursor B
was used as a reaction substrate, lower yields were observed for
both the amino acid and the peptide labelling reactions. This
is probably due to the instability of Fc-methylene com-
pounds.31,32 The harsh conditions of the click reaction (80 °C
for 1 h) most probably led to partial decomposition of the
ferrocene derivative. Nevertheless, products 2B and 3B could
be isolated in 29% and 6.5% yields, respectively. For 2B, the
HR ESI-MS analysis showed the [M − H]− peak at m/z 575.1391
(calculated value: 575.1387). In addition, the 13C-NMR revealed
the carbon signals of the newly formed triazole moiety at
144.70 and 124.25 ppm. Furthermore, 2D experiments corre-
lated the resonance at 124.25 ppm to the broad peak at
7.77 ppm in the 1H-NMR, which could be then assigned to the
triazole CH. For 3B, MALDI-TOF analysis showed the most
intense peak at m/z 1172.6, which can be attributed to [M +
H]+.
Photoclick reaction
As a parallel approach to the one-pot click reaction, we investi-
gated the applicability of the photoclick reaction to our
metal precursors, to pursue a more biocompatible method for
organometallic labelling. This procedure exploits the light-
mediated formation of a reactive acyl-nitrene intermediate
from a tetrazole group. This activated intermediate is then
prone to 1,3-dipolar cycloaddition with a substituted alkene.23
This reaction belongs to the class of photo-mediated ortho-
gonal reactions, which have been extensively exploited for in vivo
applications due to their high selectivity and the lack of the
toxic copper catalyst.20,21,33–35 The diphenyltetrazole group 7,
which was synthesized as previously reported,36 was installed
on the PNA backbone 8,37 to obtain a tetrazole-containing PNA
monomer as a t-Bu ester 9 (Fig. 4). Removal of the t-Bu yielded
compound 10, which can be inserted into a PNA or a peptide
sequence by solid phase synthesis. The initial design of the
system envisaged the use of a phenyl-allyloxy derivative as the
alkene-reactive component. However, this molecule was found
to be poorly reactive and only aﬀorded the products in low
yields. For these reasons, we decided to employ a maleimide
group as alkene functionality. Maleimide derivatives of cyman-
trene and ferrocene (4A and 4B, Fig. 5) were therefore prepared
and “photoclicked” with the protected PNA monomer 9
bearing the tetrazole reactive moiety. The Fc-containing com-
pound 5B was isolated in 63% yield and fully characterized.
The UV chromatogram of UPLC analysis showed one peak and
the HR ESI-MS showed a peak at m/z 912.3041, corresponding
to [M + H]+ (calculated: 912.3054). On the other hand, the Mn
derivative 5A was isolated from the crude as a minor com-
ponent (8.5%), whereas the main product of the reaction
(40%) was still a product of photoclick lacking, however, the
Mn(CO)3 moiety (m/z 891.5 [M − Mn(CO)3 + H]+). Comparison
of the IR spectra confirmed the absence of the CuO vibrations
in the spectrum of the product isolated in higher amount,
signals which are well visible in the IR spectrum of 5A (1927
and 2019 cm−1). This outcome is probably due to the known
ability of cymantrenyl compounds to release CO upon light
irradiation.38 Therefore, it is likely that the product of the
photoclick decomposes during the reaction.
Motivated by the successful formation of 5B, we attempted
the insertion of ferrocene-maleimide in a NLS peptide carrying
Fig. 3 One-pot click reactions. (a) TfN3, CuSO4, NaHCO3, H2O/MeOH/
DCM, 30 min, RT. (b) Fmoc-L-Pra-OH, TBTA, CuSO4, Na ascorbate, 1 h,
MW 80 °C. (c) NLS-Pra, TBTA, CuSO4, Na ascorbate, 1 h, MW 80 °C. All
amine groups in the peptide sequence are present as TFA salts.
Fig. 4 Synthesis of the tetrazole-containing PNA monomer. (a) HATU,
HOBt, DIPEA, DMF, o.n., RT. (b) DCM : TFA : TIPS 2 : 1 : 0.4, o.n., RT.
Fig. 5 Photoclick reaction. (a) Maleic anhydride, AcOH, 8 h, reﬂux. (b)
9, ACN, 302 nm, 1 h, RT. (c) NLS-tetra, H2O or ACN : PBS (5 : 1), 302 nm,
30 min, RT. (d) NLS-tetra, DMSO, 302 nm, 1 h, RT. All amine groups in
the peptide sequence are present as TFA salts.
Inorganic Chemistry Frontiers Research Article
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the modified PNA monomer (NLS-tetra, Fig. 2), synthesized by
solid phase synthesis.28 In a procedure reporting on the modi-
fication of a DNA strand with a maleimide functionalized dye
via photoclick, this reaction was performed in PBS aﬀording
yields in the range of 8–34% depending on the conditions
used, whilst the use of DMSO as solvent did not aﬀord the
desired product.39 Surprisingly, when we performed the
reaction in water or ACN : PBS (5 : 1), after just 30 min
irradiation NLS-tetra was found to have entirely turned into
the hydrolysis byproduct of the acyl-nitrene intermediate
(Fig. 5, ESI-MS (pos. detection mode): m/z [M + 3H]3+ 318.4,
[M + 2H]2+ 476.9, [M + H]+ 952.6. UPLC r.t. (2.5 min): 0.3 min).
By performing the reaction in DMSO and upon 1 h irradiation,
we could obtain, next to the hydrolysis compound, the
expected product 6B in 20% yield. MALDI-TOF analysis
confirmed the identity of the compound, showing a peak at
m/z 1229.6 [M + H]+.
PNA functionalization with photoclick
In order to assess the full potential of the photoclick synthetic
procedure, we applied it to a PNA sequence. PNAs are DNA/
RNA mimics which were first reported by Nielsen et al.40 They
have gained significant interest owing to their ability to hybri-
dize with DNA/RNA complementary strands with very high
aﬃnity, their proven stability to nuclease and protease degra-
dation and their lack of unspecific interactions with proteins.
Thanks to these characteristics, PNAs are very promising for
several applications ranging from nanotechnology41,42 to
in vivo antisense therapy43 and tumour pre-targeting.8 However,
there is room for improvement of the potential of PNAs in bio-
logical applications, for example by increasing their low
solubility in physiological environment or by equipping them
with a probe for cellular localization. It is therefore important
to develop techniques for PNA functionalization. In particular,
substitution with metal complexes have been of great interest
to exploit additional properties of the new PNA–metal
complex conjugate.8,15,16,37,44–51 In this work, we applied photo-
click to achieve the insertion of a ferrocene moiety into a PNA
sequence that was previously applied as an antisense agent on
hepatitis B virus.52 This sequence, which was synthesized via
solid phase synthesis,53 was further modified with the inser-
tion of the PNA monomer bearing the modified tetrazole and
a cysteine for conjugation via Michael addition (PNA, Fig. 2).
The photoclick reaction was performed several times to opti-
mize the conditions and the structures of the isolated products
are reported in Fig. 6. Having the PNA sequence as substrate,
the reaction showed a similar behaviour to that reported pre-
viously with the DNA strand.39 When DMSO was used as
solvent, the PNA starting material was converted to the hydro-
lyzed form of the acyl-nitrene intermediate 14. Therefore, in
the second trial, the reaction was performed in water with 1
eq. of 4B. After 1 h irradiation, we could isolate all the pro-
ducts reported in Fig. 6. The photoclick product 11, containing
a single Fc moiety, was isolated in 6.5% yield. The doubly Fc
labelled PNA 12 was also formed in 8% yield, due to the occur-
rence of both photoclick and Michael addition. Furthermore
13, a PNA containing the hydrolyzed tetrazole and the ferro-
cene conjugated at the cys group via Michael addition, was iso-
lated in 14% yield. Due to the presence of water, the main
component of the mixture was found to be the unlabelled
hydrolyzed product 14 (30%). Next to these components, two
compounds with m/z 5380 and 5566, respectively were isolated
but their structures were not elucidated. In the attempt to
improve the labelling eﬃciency, increasing amounts of 4B
were used (5 eq.). The yield of formation of the photoclick
product 11 could be increased to 10%. Additionally, the
double Fc containing 12 was isolated in 2.6% yield, the hydro-
lyzed intermediate 14 in 17% yield and 13 in 36% yield. The
Fig. 6 Products of the reaction between PNA and 4B upon 302 nm light irradiation. All amine groups in the PNA sequences are present as TFA
salts.
Research Article Inorganic Chemistry Frontiers
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component with m/z 5566 was also formed. As became evident
from the last reaction conditions used, it is possible to
increase the formation of the photoclick product by increasing
the amount of the Fc-maleimide starting material. The kinetic
of the competing Michael reaction seems however to be faster
than the one of the photoclick, therefore, higher yields could
be obtained if the cysteine would not be present.
Experimental
Instruments and methods
All commercial chemicals were used without further purifi-
cation. 1H and 13C NMR measurements were carried out on
Bruker 400 and 500 spectrometers and referenced to residual
solvent peaks. The abbreviations for the peak multiplicities are
as follows: s (singlet), bs (broad singlet), d (doublet), dd
(doublet of doublets), t (triplet), q (quartet), m (multiplet).
UV spectra were recorded on a Varian Cary 100 spectro-
photometer. Elemental microanalyses were performed on a
LecoCHNS-932 elemental analyser. ESI-MS and R.P. UPLC-MS
were performed using a Bruker Daltonics HCT 6000 mass
spectrometer. R.P. UPLC-MS spectra were recorded on a Waters
Acquity™ system equipped with a PDA detector and an auto-
sampler. R.P. UPLC-MS was performed on an Acquity UPLC
BEH C18 column (21.50 × 1.7 mm). The UPLC run (flow rate:
0.6 mL min−1) was carried out with a linear gradient of A
(double distilled water containing 0.1% v/v formic acid) and B
(acetonitrile): t = 0 min, 5% B; t = 0.25 min, 5% B; t = 1.5 min,
100% B; t = 2.5 min, 100% B. High resolution ESI-MS spectra
were recorded using a Bruker ESQUIRE-LC quadrupole ion
trap instrument. The matrix-assisted laser desorption/ioniza-
tion time of flight mass spectrometry (MALDI-TOF) mass
spectra were measured on a Bruker Daltonics Autoflex. The
experiments were performed in reflector (RP) or linear (LP)
mode using α-cyano-4-hydroxy-cinnamic acid on a Prespotted
Anchor Chip (PAC HCCA) or sinapinic acid (SA) as the matrix.
Preparative HPLC purification was carried out on a Varian
ProStar system and an Agilent Zorbax 300 SB-C18 prep column
(5 μm particle size, 300 Å pore size, 150 × 21.2 mm, flow rate:
20 mL min−1). The runs were performed with a linear gradient
of A (double distilled water containing 0.1% v/v trifluoroacetic
acid) and B (acetonitrile, Sigma-Aldrich HPLC grade). Micro-
wave reactions were performed using a Biotage Initiator +
Robot Eight instrument in 2.5 mL sealed microwave vials. UV
irradiation at 302 nm were performed using a handheld UV
lamp UVM-57, 6 Watt from UVP, Cambridge, UK. Samples
were irradiated in a Starna GmbH 1.4 or 3.5 mL fluorescence
quartz cuvette (width 1 cm) while stirring.
Syntheses
A, B, 7, 8 were synthesized as previously described. All ana-
lytical data match with that reported in the literature.24,25,36,37
Fmoc-PNA-tetra-OtBu 9. The protected PNA backbone 8 as
the chloride salt (517 mg, 1.195 mmol, 1.0 eq.) was dissolved
in DCM (100 mL) and washed with NaHCO3 (2 × 40 mL). The
aqueous solution was back-extracted with DCM (2 × 30 mL).
The organic phases were reunited and evaporated using a
rotary evaporator to yield a yellow oil. 7 (350 mg, 1.31 mmol,
1.1 eq.) was dissolved in 10 mL of DMF. HATU (500 mg,
1.31 mmol, 1.1 eq.), HOBt (275 mg, 2.03 mmol, 1.7 eq.) and
DIPEA (340 μL, 2.03 mmol, 1.7 eq.) were then added to this
solution and the mixture stirred for 20 min. The yellow oil con-
taining 8 in 5 mL DMF was added to the mixture containing 7.
The mixture was stirred overnight. Afterwards, the solvent was
removed at the rotary evaporator. The crude product was puri-
fied by column chromatography on silica gel with EtOAc : Hex
(1 : 1) as the eluent to isolate the product (r.f. 0.65, 630 mg,
82%) as a yellowish solid. ESI-MS (pos. detection mode): m/z
[M + Na]+ 667.2, [2M − H + Na]+ 1311.1. 1H-NMR δH (CDCl3,
500 MHz): 1.44 (s, 9H, tBu), 3.29 (bs, 1H, NHCH2CH2), 3.54
(bs, 2H, NCH2CO), 3.75 (bs, 1H, NHCH2CH2), 3.93 (bs, 1H,
CH2CH2N), 4.14 (bs, 1H, CH2CH2N), 4.24 (m, 1H, FMOC–
CHCH2), 4.29–4.40 (dd, 2H, CHCH2O), 5.68 (bs, 1H, NH),
7.29–7.33 (t, 2H, FMOC), 7.38–7.42 (t, 2H, FMOC), 7.51–7.63
(m, 7H, FMOC + Ph), 7.77–7.79 (d, 2H, FMOC), 8.16–8.29 (m,
4H, Ph). 13C-NMR (CDCl3, 126 MHz, rotamers observed):
28.10, 39.34, 47.27, 47.35, 47.59, 49.14, 67.14, 120.04, 120.11,
125.26, 125.31, 127.21, 127.32, 127.46, 127.83, 129.86, 136.94,
141.43, 144.09, 156.29, 156.90, 164.52, 168.98, 169.23, 171.90,
172.64. HR ESI-MS calc for C37H37N6O5 [M + H]
+ 645.2028,
found 645.2818, calc for C37H36N6O5Na [M + Na]
+ 667.2639,
found 667.2636.
Fmoc-PNA-tetra-OH 10. 9 (350 mg, 0.54 mmol) was dis-
solved in 17 mL of a DCM : TFA : TIPS (2 : 1 : 0.4) solution. The
mixture was stirred overnight at room temperature. The
solvent was then removed at the rotary evaporator and the
crude product purified by column chromatography on silica
gel with eluent EtOAc : MeOH (10 : 3) to isolate the product as
a white powder (r.f. 0.55, 320 mg, 90%). ESI-MS (pos. detection
mode): m/z [M + H]+ 589.3, [2M + H]+ 1178.5. 1H-NMR
δH (acetone-d6, 500 MHz): 3.34 (m, 1H, NHCH2CH2), 3.52
(m, 1H, NHCH2CH2), 3.58 (m, 1H, CH2CH2N), 3.73 (m, 1H,
CH2CH2N), 4.19 (m, 1H, FMOC–CHCH2), 4.25 (s, 2H,
NCH2COOH), 4.33–4.39 (dd, 2H, CHCH2O), 6.60 (bs, 1H, NH),
7.30–7.33 (t, 2H, FMOC), 7.39–7.42 (t, 2H, FMOC), 7.60–7.66
(m, 3H, Ph), 7.70–7.72 (m, 4H, FMOC + Ph), 7.86–7.88 (d, 2H,
FMOC), 8.20–8.23 (m, 4H, Ph). 13C-NMR (acetone-d6,
126 MHz): 41.31, 47.42, 48.00, 50.53, 67.13, 120.78, 126.08,
127.63, 127.74, 127.94, 128.31, 128.54, 128.69, 130.90, 130.94,
137.78, 139.60, 142.15, 145.17, 156.98, 165.37, 171.28, 171.81.
HR ESI-MS calc for C33H29N6O5 [M + H]
+ 589.2194, found
589.2196.
NLS-Pra, NLS-tetra and PNA. The peptides and the PNA
sequences were synthesized by solid phase synthesis, as pre-
viously reported by our group on a TENTA Gel-S-RAM
resin.28,53 All the amine groups in peptide and PNA sequences
are present as TFA salts. NLS-Pra: ESI-MS (pos. detection
mode): m/z [M + H]+ 931.6, [M + 2H]2+ 466.4, [M + 3H]3+ 311.4.
UPLC r.t. (2.5 min): 0.8 min. NLS-tetra: ESI-MS (pos. detection
mode): m/z [M + H]+ 962.7, [M + 2H]2+ 481.9, [M + 3H]3+ 321.7.
UPLC r.t. (2.5 min): 0.7 min. PNA: ESI-MS (pos. detection
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mode): m/z [M + 6H]6+ 865.2, [M + 7H]7+ 741.8, [M + 8H]8+
649.2, [M + 9H]9+ 577.1. UPLC r.t. (2.5 min): 0.9 min.
Mn-maleimide 4A. A as trifluoroacetate salt (30 mg,
0.067 mmol, 1.0 eq.) and maleic anhydride (66 mg,
0.67 mmol, 10.0 eq.) were dissolved in glacial acetic acid
(1 mL) and then refluxed for 8 h. The solvent was then evapo-
rated using a high vacuum pump. The crude product was then
purified by column chromatography on silica gel with DCM :
MeOH (100 : 2.5) as the eluent. The product was isolated as the
first band (r.f. 0.67). The solvent was removed using a rotary
evaporator to yield 16.6 mg of the expected product as a light
brown oil (60%). 1H-NMR δH (CDCl3, 500 MHz): 1.79 (m, 2H,
CH2CH2CH2), 2.18 (t, 2H, CpCH2CH2), 2.26 (t, 2H,
CH2CH2CO), 3.45–3.47 (m, 2H, NHCH2CH2), 3.69–3.70 (m, 2H,
CH2CH2NH), 4.63 (s, 4H, Cp), 5.81 (br s, 1H, NH), 6.73 (s, 2H,
maleimide). 13C-NMR (CDCl3, 126 MHz): 26.68, 27.74, 35.85,
37.76, 39.17, 81.96, 106.32, 134.43, 171.10, 172.62, 225.33.
ESI-MS (pos. detection mode): m/z [M + H+] 413.1. UPLC r.t.
(2.5 min): 1.3 min.
Fc-maleimide 4B. B (30 mg, 0.140 mmol, 1.0 eq.) and
maleic anhydride (137 mg, 1.40 mmol, 10.0 eq.) were dissolved
in glacial acetic acid (1 mL) and then refluxed for 6 h. The
solvent was then evaporated using a high vacuum pump. The
crude product was then purified by column chromatography
on silica gel with DCM as the eluent. The product was isolated
as the first orange band (r.f. 0.75). The solvent was removed
using a rotary evaporator to yield 1.8 mg of product (4%).
1H-NMR δH (CDCl3, 500 MHz): 4.10 (m, 2H, Cp), 4.17 (s, 5H,
Cp), 4.28 (m, 2H, Cp), 4.44 (s, 2H, CH2), 6.64 (s, 2H, male-
imide). 13C-NMR (CDCl3, 126 MHz): 37.20, 68.47, 68.78, 69.54,
134.18, 170.48. ESI-MS (pos. detection mode): m/z [M]+ 295.0.
UPLC r.t. (2.5 min): 1.6 min.
2A. A (20 mg, 0.045 mmol, 1.0 eq.) in 30 μL of MeOH,
CuSO4 (0.143 mg, 0.0009 mmol, 0.02 eq.) in 15 μL of H2O and
NaHCO3 (7.6 mg, 0.089 mmol, 2.0 eq.) in 200 μL of H2O were
mixed in a 10 mL round bottom flask. TfN3 (0.134 mmol,
3.0 eq.), freshly prepared as previously reported,22 in 124 μL of
DCM was then added to this mixture. 1.6 mL of MeOH were
added to the solution to make it homogeneous. The mixture
was then stirred for 30 min until both TLC (Hex : EtOAc 1 : 1)
and UPLC (r.t. 1.35 min, m/z = 359.1) confirmed the full con-
version of the amine group to the azide. The mixture was then
transferred in a microwave reactor and the following reagents
were added to it: Fmoc-L-Pra-OH (15.1 mg, 0.045 mmol,
1.0 eq.), TBTA (2.4 mg, 0.0045 mmol, 0.1 eq.) in 254 μL of
MeOH, CuSO4 (0.143 mg, 0.0009 mmol, 0.02 eq.) in 15 μL of
H2O and Na ascorbate (1.78 mg, 0.009 mmol, 0.2 eq.) in
154 μL of H2O and 0.5 mL of MeOH to help full dissolution.
The mixture was refluxed in the MW oven for 1 h at 80 °C (60
W). The solvent was removed at the rotary evaporator and the
mixture was purified by column chromatography on silica gel
with DCM :MeOH (10 : 1) as the eluent to isolate the product
(r.f. 0.27, 50%). Another batch was purified by preparative r.p.
HPLC (linear gradient of A (double distilled water containing
0.1% v/v trifluoroacetic acid) and B (acetonitrile): t = 0–3 min 25% B,
t = 33 min 100% B, t = 35 min 100% B, flow rate 20 mL min−1,
detection 275 nm) to aﬀord the same product. ESI-MS (neg.
detection mode): m/z [M − H]− 692.1. UPLC r.t. (2.5 min):
1.40 min. HR ESI-MS calc for C34H31MnN5O8 [M − H]−
692.1559, found 692.1565. 1H-NMR not meaningful due to
traces of paramagnetic impurities. 13C-NMR (MeOH-d4,
126 MHz): 27.91, 28.46, 29.23, 30.41, 55.73, 67.68, 82.85, 83.41,
107.49, 120.68, 125.88, 127.91, 128.54, 142.29, 144.97, 226.32.
Some quaternary signals not observed.
2B. B (20 mg, 0.093 mmol, 1 eq.) in 158 μL of MeOH, CuSO4
(0.297 mg, 0.00186 mmol, 0.02 eq.) in 30 μL of H2O and
NaHCO3 (15.7 mg, 0.186 mmol, 2 eq.) in 424 μL of H2O were
mixed in a 10 mL round bottom flask. TfN3 (0.279 mmol,
3 eq.), freshly prepared as previously reported,22 in 258 μL of
DCM was added to the mixture. 2.5 mL of MeOH were added
to the solution to make it homogeneous. The mixture was
stirred for 1 h, until when both TLC (Hex : EtOAc 1 : 1) and
UPLC (r.t. 1.60 min, m/z = 240.9) confirmed the full conversion
of the amine group to azide. Then the mixture was transferred
in a microwave reactor and the following reagents were added
to it: Fmoc-L-Pra-OH (31.2 mg, 0.093 mmol, 1 eq.), TBTA
(4.9 mg, 0.0093 mmol, 0.1 eq.) in 526 μL of MeOH, CuSO4
(0.297 mg, 0.00186 mmol, 0.02 eq.) in 30 μL of H2O and Na
ascorbate (3.68 mg, 0.0186 mmol, 0.2 eq.) in 380 μL of H2O
and 0.5 mL of MeOH to help full dissolution. The mixture was
refluxed in MW oven for 1 h at 80 °C (60 W). After the reaction
time, the solvent was removed using a rotary evaporator and
the mixture was purified by column chromatography on silica
gel with DCM :MeOH (10 : 1) as the eluent, to isolate the
product (r.f. 0.52, 29%). Another batch was purified by pre-
parative r.p. HPLC (linear gradient of A (double distilled water
containing 0.1% v/v trifluoroacetic acid) and B (acetonitrile):
t = 0–3 min 25% B, t = 33 min 100% B, t = 35 min 100% B,
flow rate 20 mL min−1, detection 275 nm) to aﬀord the same
compound. ESI-MS (neg. detection mode): m/z [M − H]− 575.1,
[2M − H]− 1151.3. UPLC r.t. (2.5 min): 1.55 min. HR ESI-MS
calc for C31H27FeN4O4 [M − H]− 575.1387, found 575.1391.
1H-NMR δH (MeOH-d4, 500 MHz): 3.04–3.09 (m, 1H,
triazCH2CH), 3.33 (below MeOH, m, 1H, triazCH2CH),
4.14–4.26 (m, 12H, Fc, OCH2CH, CH2CHFmoc), 4.49–4.51
(m, 1H, NHCHCOOH), 7.32–7.35 (m, 2H, Fmoc), 7.42–7.45
(m, 2H, Fmoc), 7.62–7.67 (m, 2H, Fmoc), 7.77 (bs, 1H, triaz),
7.85–7.87 (m, 2H, Fmoc). 13C-NMR (MeOH-d4, 126 MHz):
28.85, 48.27, 51.09, 55.13, 68.26, 121.16, 121.19, 124.25,
126.60, 126.61, 128.43, 129.03, 129.05, 142.67, 142.72, 144.70,
145.33, 145.37, 158.59, 174.59 (Fc signals below MeOH).
3A. A (10 mg, 0.0224 mmol, 1.0 eq.) in 254 μL of MeOH,
CuSO4 (0.071 mg, 0.00045 mmol, 0.02 eq.) in 11 μL of H2O and
NaHCO3 (3.8 mg, 0.0448 mmol, 2.0 eq.) in 100 μL of H2O were
mixed in a 10 mL round bottom flask. Then TfN3 (0.067 mmol,
3.0 eq.), freshly prepared as previously reported, in 34 μL of
DCM was added to the mixture. 500 μL of MeOH were added
to the mixture to make it homogeneous. The mixture was
stirred for 30 min, until when both TLC (Hex : EtOAc 1 : 1) and
UPLC (r.t. 1.35 min, m/z = 359.1) confirmed the full conversion
of the amine group to azide. Then the mixture was transferred
in a microwave reactor and the following reagents were added
Research Article Inorganic Chemistry Frontiers
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to it: NLS-Pra as TFA salt (31.07 mg, 0.0224 mmol, 1 eq.) in
2.24 mL of H2O, TBTA (1.19 mg, 0.00224 mmol, 0.1 eq.) in
474 μL of MeOH, CuSO4 (0.071 mg, 0.00045 mmol, 0.02 eq.) in
11 μL of H2O and Na ascorbate (0.888 mg, 0.00448 mmol,
0.2 eq.) in 81 μL of H2O and 2.5 mL of MeOH to help full
dissolution. The mixture was refluxed in MW oven for 1 h at
80 °C (60 W). After the reaction time, the solvent was removed
using a rotary evaporator and the crude was purified by
preparative r.p. HPLC (linear gradient of A (double distilled
water containing 0.1% v/v trifluoroacetic acid) and B (aceto-
nitrile): t = 0–1.48 min 5% B, t = 38 min 100% B, t = 40 min
100% B, flow rate 20 mL min−1, detection 275 nm). Chromato-
graphic yield: 65%. ESI-MS (pos. detection mode): m/z [M + H]+
1289.6, [M + 2H]2+ 645.8, [M + 3H]3+ 430.7. UPLC r.t. (2.5 min):
0.9 min. MALDI-TOF [M −Mn(CO)3 + H]+ 1151.7, [M −Mn(CO)3 +
Na]+ 1173.7, [M −Mn(CO)3 + K]+ 1189.6, [M + H]+ 1289.6.
3B. B (2.73 mg, 0.0127 mmol, 1.0 eq.) in 57 μL of MeOH,
CuSO4 (0.04 mg, 0.00025 mmol, 0.02 eq.) in 4 μL of H2O and
NaHCO3 (2.14 mg, 0.025 mmol, 2.0 eq.) in 57 μL of H2O were
mixed in a 10 mL round bottom flask. Then TfN3 (0.038 mmol,
3 eq.), freshly prepared as previously reported, in 35 μL of
DCM was added to the mixture. 400 μL of MeOH were added
to the solution to make it homogeneous. The mixture was
stirred for 1 h, until when both TLC (Hex : EtOAc 1 : 1) and
UPLC (r.t. 1.35 min, m/z = 240.9) confirmed the full conversion
of the amine group to the azide. Then the mixture was trans-
ferred in a microwave reactor and the following reagents were
added to it: NLS-Pra as TFA salt (17.6 mg, 0.0127 mmol, 1 eq.)
in 760 μL of H2O, TBTA (0.672 mg, 0.00126 mmol, 0.1 eq.) in
71 μL of MeOH, CuSO4 (0.04 mg, 0.00025 mmol, 0.02 eq.) in
4 μL of H2O and Na ascorbate (0.50 mg, 0.00254 mmol, 0.2
eq.) in 44 μL of H2O and 1 mL of MeOH to help full dissol-
ution. The mixture was refluxed in MW oven for 1 h at 80 °C
(60 W). After the reaction time, the solvent was removed using
a rotary evaporator and the crude was purified by preparative r.
p. HPLC (linear gradient of A (double distilled water contain-
ing 0.1% v/v trifluoroacetic acid) and B (acetonitrile): t =
0–1.48 min 5% B, t = 38 min 100% B, t = 40 min 100% B, flow
rate 20 mL min−1, detection 275 nm method). Chromato-
graphic yield: 6.5%. ESI-MS (pos. detection mode): m/z [M −
Fc − CH2 + 3H]3+ 325.7, [M + 3H]3+ 391.7, [M − Fc − CH2 +
2H]2+ 487.9, [M + 2H]2+ 586.9, [M + H]+ 1172.6. UPLC r.t.
(2.5 min): 0.9 min. MALDI-TOF [M + H]+ 1172.6.
5A. 4A (4.48 mg, 0.011 mmol, 1 eq.) and 9 (7 mg,
0.011 mmol, 1 eq.) were dissolved in 3 mL CH3CN in a fluo-
rescence quartz cuvette and irradiated at 302 nm for 1 h. The
mixture turned yellow during irradiation. The solvent was
removed at rotatory evaporator and the crude was purified by
preparative r.p. HPLC (linear gradient of A (double distilled
water containing 0.1% v/v trifluoroacetic acid) and B (aceto-
nitrile): t = 0–3 min 25% B, t = 33 min 100% B, t = 35 min
100% B, flow rate 20 mL min−1, detection 275 nm), to isolate
5A (chromatographic yield: 8.5%) and the byproduct without
the fragment Mn(CO3) (chromatographic yield: 40%). ESI-MS
(pos. detection mode): m/z [M + H]+ 1029.4, [M + H − tBu]+
973.3. UPLC r.t. (2.5 min): 1.8 min.
5B. 4B (1.2 mg, 0.004 mmol, 1 eq.) and 9 (2.63 mg,
0.004 mmol, 1 eq.) were dissolved in 0.6 mL CH3CN in a fluo-
rescence quartz cuvette and irradiated at 302 nm for 1 h. The
mixture turned yellow during irradiation. The solvent was
dried at rotatory evaporator and the crude was purified by
column chromatography on silica gel with eluent DCM :MeOH
(10 : 1). The yellow spot was isolated (r.f. 0.3) to yield the
product and a yellow/green solid (2.3 mg, 63%). 1H-NMR not
meaningful due to traces of paramagnetic impurities.
13C-NMR (CDCl3, 126 MHz): 28.27, 29.41, 29.83, 39.41, 47.37,
65.98, 67.18, 114.74, 120.18, 121.97, 125.39, 127.36, 127.93,
129.34, 132.07, 136.33, 141.47, 144.16, 169.30. Some quatern-
ary signals not observed. ESI-MS (pos. detection mode): m/z
[M]+ 911.4. HR ESI-MS calc for C52H50FeN5O7 [M + H]
+
912.3054, found 912.3041. UPLC r.t. (2.5 min): 1.8 min.
6B. 4B (0.191 mg, 0.00065 mmol, 1 eq.) and NLS-tetra as
TFA salt (1 mg, 0.00065 mmol, 1 eq.) were dissolved in 1 mL of
DMSO and irradiated in a luminescence quartz cuvette for 1 h.
The mixture was purified by preparative r.p. HPLC (linear gra-
dient of A (double distilled water containing 0.1% v/v trifluor-
oacetic acid) and B (acetonitrile): t = 0–1.48 min 5% B, t =
38 min 100% B, t = 40 min 100% B, flow rate 20 mL min−1,
detection 275 nm). Chromatographic yield: 20%. ESI-MS
(pos. detection mode): m/z [M + 4H]4+ 308.3, [M + 3H]3+ 410.7,
[M + 2H]2+ 615.4. UPLC r.t. (2.5 min): 0.9 min. MALDI-TOF
[M + H]+ 1229.6.
Fc-PNA 11. 4B (0.54 mg, 0.00184 mmol, 5 eq.) and PNA as
TFA salt (2.5 mg, 0.00037 mmol, 1 eq.) were dissolved in 1 mL
of H2O in a quartz luminescence cuvette and irradiated for
1 h. The components of the mixture were isolated by prepara-
tive r.p. HPLC (linear gradient of A (double distilled water con-
taining 0.1% v/v trifluoroacetic acid) and B (acetonitrile): t =
0–1.48 min 5% B, t = 38 min 100% B, t = 40 min 100% B, flow
rate 20 mL min−1, detection 275 nm). 11: 10%, ESI-MS
(pos. detection mode): m/z [M + 6H]6+ 909.7, [M + 7H]7+ 780.0,
[M + 8H]8+ 682.6, [M + 9H]9+ 606.8. UPLC r.t. (2.5 min):
0.7 min. MALDI-TOF: m/z 5448.2 [M]+. 12: 2.6%, ESI-MS (pos.
detection mode): m/z [M + 6H]6+ 959.0, [M + 7H]7+ 822.1,
[M + 8H]8+ 719.5, [M + 9H]9+ 639.7, [M + 10H]10+ 575.7. UPLC
r.t. (2.5 min): 1.0 min. MALDI-TOF: m/z 5744.9 [M]+. 13: 36%,
ESI-MS (pos. detection mode): m/z [M + 5H]5+ 1094.8,
[M + 6H]6+ 912.7, [M + 7H]7+ 782.5, [M + 8H]8+ 684.8. UPLC r.t.
(2.5 min): 0.8 min. MALDI-TOF: m/z 5466.8 [M]+. 14: 17%,
ESI-MS (pos. detection mode): m/z [M + 5H]5+ 1035.8,
[M + 6H]6+ 863.6, [M + 7H]7+ 740.3, [M + 8H]8+ 648.1. UPLC r.t.
(2.5 min): 0.7 min.
Conclusions
The functionalization of biologically relevant molecules with
metal complexes is a very intriguing topic nowadays. The inser-
tion of a metal fragment can strongly improve the properties
of the system, from a therapeutic or diagnostic point of view as
well as for the investigation of biological mechanisms. The use
of copper-catalyzed azide–alkyne cycloaddition is deeply
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exploited for the functionalization of biomolecules, but some
drawbacks limit its application for example in vivo. Therefore,
the optimization of modified click procedure was extensively
studied in the recent years. In this paper we present the use of
modified click strategies (namely one-pot click and photoclick)
to insert organometallic fragments in peptides and PNA
sequences. One-pot click allows for the in situ conversion of an
amine to the azide intermediate, which is then directly clicked
with the alkynyl counterpart. Therefore, the isolation of the
azide containing compound is not required, relieving the
safety concerns linked to the manipulation of azide com-
pounds. We obtained high labelling eﬃciencies using one-pot
click on an amine derivative of cymantrene for derivatization of
both a model alkynyl amino acid and a NLS peptide carrying
this amino acid. When a ferrocene derivative was used as an
amine substrate, yields were found to be lower. The harsh con-
ditions used for one-pot click (1 h of microwave assisted reflux
at 80 °C) might lead to the decomposition of the methyl-
aminoferrocene precursor. We also investigated the appli-
cation of metal-free photoclick to our metal-containing
precursors, to establish a biocompatible strategy for organo-
metallic derivatization of biomolecules. While the use of cyman-
trene as substrate for photoclick yielded mainly a by product of
the light-mediated CO release from the metal core, the appli-
cation of photoclick to a ferrocene-maleimide derivative
allowed for fast and eﬀective functionalization of both a tetra-
zole-derivatized PNA monomer and a NLS peptide containing
this PNA residue. This technique was also used for Fc insertion
into a 15-mer PNA sequence carrying the tetrazole group, with
yields comparable to those of a previously reported photoclick
application for dsDNA functionalization.39 Overall, we envisage
the application of these very versatile techniques for the
functionalization of biomolecules with other metal complexes.
As a result, a wide range of metal fragments could be intro-
duced into bioactive systems to prepare novel diagnostic tools
useful to study cellular mechanisms. One could also imagine
that novel therapeutic entities could be designed, for example,
with the introduction of ruthenium complexes into targeting
peptides to obtain selective compounds for traditional chemo-
therapy or photodynamic therapy. Overall, this study will
expand the pool of metal-based probe-containing systems,
which can be profitably applied in chemical biology or in med-
icinal chemistry.
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